The company is offering shares at an expected price between $4.50 and $5.50 per share with an insider lock-up period of 180 days ending on August 20, 2025.

Aspire Biopharma (ASBP) and PowerUp Acquisition (PWUP) announced the completion of their previously announced business combination. Proceeds ...

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing ...

Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development InitiativesBANGKOK, Feb. 20, 2025 ...

NewGenIvf Group (NIVF) announced that the Nasdaq Hearings Panel has granted the company’s request for continued listing on Nasdaq, subject to ...

Bio (IBIO) announced that iBio’s common stock has been approved for listing on Nasdaq and iBio will transfer its stock exchange listing to ...

Some small IPOs are tentatively scheduled for the short holiday week ahead. Space and defense contractor Karman Holdings ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to ... This came as a surprise because, at the time of its IPO ...

Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

(photo credit: Andrew Kelly/Reuters) The first Israeli IPO on Nasdaq in 2025 is expected to take place soon, when tech company Odysight.ai (OTC: ODYS) will seek to raise $21.5 million at a company ...